BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20001613)

  • 1. Current understanding in the management of sickle cell disease.
    Inati A; Chabtini L; Mounayar M; Taher A
    Hemoglobin; 2009; 33 Suppl 1():S107-15. PubMed ID: 20001613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current issues in blood transfusion for sickle cell disease.
    Wahl S; Quirolo KC
    Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines.
    Josephson CD; Su LL; Hillyer KL; Hillyer CD
    Transfus Med Rev; 2007 Apr; 21(2):118-33. PubMed ID: 17397762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype.
    Bonds DR
    Blood Rev; 2005 Mar; 19(2):99-110. PubMed ID: 15603913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease.
    Pack-Mabien A; Haynes J
    J Am Acad Nurse Pract; 2009 May; 21(5):250-7. PubMed ID: 19432908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease in pregnancy. Obstetric and anesthetic management perspectives.
    Rajab KE; Skerman JH
    Saudi Med J; 2004 Mar; 25(3):265-76. PubMed ID: 15048161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
    Michel M; Habibi A; Godeau B; Bachir D; Lahary A; Galacteros F; Fifi-Mah A; Arfi S
    Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron in sickle-cell disease: what have we learned over the years?
    Inati A; Khoriaty E; Musallam KM
    Pediatr Blood Cancer; 2011 Feb; 56(2):182-90. PubMed ID: 21157888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection in sickle cell disease: a review.
    Booth C; Inusa B; Obaro SK
    Int J Infect Dis; 2010 Jan; 14(1):e2-e12. PubMed ID: 19497774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current knowledge in the management of children and adolescents with sickle cell disease: Part 1, Physiological issues.
    Simon K; Lobo ML; Jackson S
    J Pediatr Nurs; 1999 Oct; 14(5):281-95. PubMed ID: 10554441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.
    Nur E; Biemond BJ; Otten HM; Brandjes DP; Schnog JJ;
    Am J Hematol; 2011 Jun; 86(6):484-9. PubMed ID: 21544855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in improving the management of sickle cell disease.
    Inati A
    Blood Rev; 2009 Dec; 23 Suppl 1():S9-13. PubMed ID: 20116638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease; a general overview.
    Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
    Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
    Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
    Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in sickle cell disease.
    Lee MT; Rosenzweig EB; Cairo MS
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children.
    de Montalembert M; Ferster A; Colombatti R; Rees DC; Gulbis B;
    Am J Hematol; 2011 Jan; 86(1):72-5. PubMed ID: 20981677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?
    Chakrabarti S; Bareford D
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):23-31. PubMed ID: 14752776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood bank management of sickle cell patients at comprehensive sickle cell centers.
    Afenyi-Annan A; Willis MS; Konrad TR; Lottenberg R
    Transfusion; 2007 Nov; 47(11):2089-97. PubMed ID: 17958539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with sickle cell disease in Jamaica: rural-urban differences.
    Asnani MR; Reid ME; Ali SB; Lipps G; Williams-Green P
    Rural Remote Health; 2008; 8(2):890. PubMed ID: 18410222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.